Literature DB >> 6132931

Pharmacokinetic properties of benzodiazepine hypnotics.

D J Greenblatt, D R Abernethy, M Divoll, J S Harmatz, R I Shader.   

Abstract

The kinetic properties of three benzodiazepine hypnotics are reviewed. Flurazepam serves as a precursor for at least two rapidly appearing and rapidly cleared metabolites that may contribute to sleep induction and are nonaccumulating. The final metabolite of flurazepam (N-desalkylflurazepam), however, has a long half-life and accumulates during repeated dosage. Temazepam has a relatively slow rate of absorption and an intermediate half-life in the range of 10 to 20 hours. Triazolam has an intermediate rate of absorption; due to its ultrashort half-life (1.5 to 5 hours), triazolam is a non-accumulating hypnotic. Taken together with sleep laboratory studies and clinical trials, knowledge of the kinetic profile of benzodiazepine hypnotics can assist in evaluating their clinical benefits and disadvantages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132931

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

Review 1.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 2.  Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective.

Authors:  U Busto; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 3.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

4.  Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites.

Authors:  L G Miller; D J Greenblatt; D R Abernethy; H Friedman; M D Luu; S M Paul; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Characterization of [3H]-imidazenil binding to rat brain membranes.

Authors:  M Lipartiti; R Arban; E Fadda; A Zanotti; P Giusti
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.